277 related articles for article (PubMed ID: 17561440)
1. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
[TBL] [Abstract][Full Text] [Related]
2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
3. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
[TBL] [Abstract][Full Text] [Related]
5. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
[TBL] [Abstract][Full Text] [Related]
7. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Chin BS; Gibbs CR; Blann AD; Lip GY
Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
[TBL] [Abstract][Full Text] [Related]
8. Respiratory effects of beta-blocker therapy in heart failure.
Agostoni P; Palermo P; Contini M
Cardiovasc Drugs Ther; 2009 Oct; 23(5):377-84. PubMed ID: 19789971
[TBL] [Abstract][Full Text] [Related]
9. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
[TBL] [Abstract][Full Text] [Related]
10. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
11. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
Kovacić D; Marinsek M; Gobec L; Lainscak M; Podbregar M
Clin Res Cardiol; 2008 Jan; 97(1):24-31. PubMed ID: 17694376
[TBL] [Abstract][Full Text] [Related]
12. Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
Magrì D; Palermo P; Cauti FM; Contini M; Farina S; Cattadori G; Apostolo A; Salvioni E; Magini A; Vignati C; Alimento M; Sciomer S; Bussotti M; Agostoni P
Cardiovasc Ther; 2012 Apr; 30(2):100-8. PubMed ID: 20553283
[TBL] [Abstract][Full Text] [Related]
13. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
14. Effects of beta-blockers on ventilation efficiency in heart failure.
Agostoni P; Apostolo A; Cattadori G; Salvioni E; Berna G; Antonioli L; Vignati C; Schina M; Sciomer S; Bussotti M; Palermo P; Fiorentini C; Contini M
Am Heart J; 2010 Jun; 159(6):1067-73. PubMed ID: 20569721
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
16. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
Podbregar M; Voga G
J Card Fail; 2002 Dec; 8(6):369-78. PubMed ID: 12528088
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
[TBL] [Abstract][Full Text] [Related]
18. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
[TBL] [Abstract][Full Text] [Related]
19. Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans.
Paolillo S; Pellegrino R; Salvioni E; Contini M; Iorio A; Bovis F; Antonelli A; Torchio R; Gulotta C; Locatelli A; Agostoni P
PLoS One; 2013; 8(4):e61877. PubMed ID: 23613962
[TBL] [Abstract][Full Text] [Related]
20. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]